tiprankstipranks
Annovis Bio (ANVS)
NYSE:ANVS
US Market

Annovis Bio (ANVS) Financial Statements

Compare
612 Followers

Annovis Bio Financial Overview

Annovis Bio's market cap is currently $32.15M. The company's EPS TTM is $-1.996; its P/E ratio is ―; Annovis Bio is scheduled to report earnings on April 8, 2025, and the estimated EPS forecast is $-0.41. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ 0.00$ -45.04M$ -25.51M$ -14.54M$ -6.64M
EBITDA$ 0.00$ -45.04M$ 0.00$ 0.00$ 0.00
Net Income$ -24.59B$ -56.20M$ -25.15M$ -14.44M$ -4.26M
Balance Sheet
Cash & Short-Term Investments$ 10.55B$ 5.75M$ 28.38M$ 45.69M$ 8.07M
Total Assets$ 13.93B$ 10.21M$ 36.02M$ 46.00M$ 8.12M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -10.55M$ -5.75M$ -28.38M$ -45.69M$ -8.07M
Total Liabilities$ 4.62B$ 17.96M$ 7.70M$ 1.51M$ 578.38K
Stockholders' Equity$ 9.31B$ -7.75M$ 28.32M$ 44.49M$ 7.54M
Cash Flow
Free Cash Flow$ -21.89B$ -39.97M$ -17.31M$ -9.13M$ -3.97M
Operating Cash Flow$ -21.89B$ -39.97M$ -17.31M$ -9.13M$ -3.97M
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 26.69B$ 17.34M$ 4.61K$ 46.74M$ 12.04M
Currency in USD

Annovis Bio Earnings and Revenue History

Annovis Bio Debt to Assets

Annovis Bio Cash Flow

Annovis Bio Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis